Nuvectra Receives Full-Body MR-Conditional CE Mark for Spinal Cord Stimulator

Nuvectra has been given a full-body MR-conditional CE Mark for its Algovita spinal cord stimulation system, the company’s first commercial attempt.

The device has already received the CE Mark and FDA approval for treating chronic intractable pain of the trunk and/or limbs.

The company is currently developing sacral neuromodulation capabilities for the system to be used in overactive bladder treatment, as well as deep brain stimulation for treating Parkinson’s disease.